Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 26;23(1):3.
doi: 10.1007/s11926-020-00970-z.

Skin Histology in Systemic Sclerosis: a Relevant Clinical Biomarker

Kimberly Showalter  1 , Jessica K Gordon  2
Affiliations
Review

Skin Histology in Systemic Sclerosis: a Relevant Clinical Biomarker

Kimberly Showalter et al. Curr Rheumatol Rep. .

Abstract

Purpose of review: Systemic sclerosis (SSc) is a life-threatening autoimmune disease that causes debilitating skin fibrosis. The skin in SSc is easily accessible, and skin biopsies may provide rich biological data regarding underlying disease pathophysiology. Here, we review literature relevant to the potential for skin histology to serve as a diagnostic, pharmacokinetic/response, and predictive biomarker in SSc.

Recent findings: Multiple histologic parameters correlate with SSc severity, including alpha smooth muscle actin (aSMA), CD34, collagen density, thickness, and inflammatory cell infiltration. Recent clinical trials incorporate skin histology as exploratory outcome measurements; however, a standard approach is not yet established. The possibility that skin histology may be useful as a predictive biomarker was suggested by a recent study that identified genes related to skin aSMA and CD34 staining intensity that were increased at baseline among improvers versus nonimprovers. Current literature supports skin histology as a mechanism to measure treatment response, but future work is needed to define minimally meaningful changes in key SSc skin histologic features.

Keywords: Biomarker; Fibroblasts; Histology; Scleroderma; Skin; Systemic sclerosis.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Medsger TA, Benedek TG. History of skin thickness assessment and the Rodnan skin thickness scoring method in systemic sclerosis. J Scleroderma Relat Disord. 2019;4(2):83–8. - DOI
    1. Foerster A. Zur pathologischen Anatomie des Scleroma der Haut by Erwachsenen [On the pathologic anatomy of scleroma of the skin in adults]. Würzburger Med Ztschr. 1861;2:294–300.
    1. Kissin EY, Merkel PA, Lafyatis R. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis. Arthritis Rheum. 2006;54(11):3655–60. - DOI
    1. • Califf RM. Biomarker definitions and their applications. Exp Biol Med (Maywood). 2018;243(3):213–21 This review explores definitions of specific types of biomarkers, an understanding of which is essential to an informed discussion regarding biomarker discovery.
    1. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–47. - DOI

LinkOut - more resources